Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ampicillin-sulbactam versus colistin for carbapenem-resistant Acinetobacter ventilator-associated pneumonia
IRCT20141209020258N126Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jun 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in ventilator-associated pneumonia (VAP) and pneumonia comparing Ampicillin-sulbactam with Colistin (2 arms). Started Jun 2018; status: completed.
02
Drugs
ampicillin + sulbactamcolistin
03
Conditions
ventilator-associated pneumonia (VAP)pneumonia
Beyond the preview
Go deeper on IRCT20141209020258N126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N126.